Pipeline Management Services for the Pharmaceutical, Healthcare, Food and MedTech Industries

Strategic management of the pharmaceutical pipeline with technology, regulatory intelligence, and a focus on generating real business in Europe and Latin America.

Pipeline Management is a strategic service that connects innovation, business development, and regulatory and commercial viability.

In the pharmaceutical industry, managing the pipeline goes far beyond identifying opportunities; it involves assessing risks, qualifying assets, structuring negotiations, and accelerating decisions with technical certainty.

ELS Group’s pharmaceutical consulting acts as a strategic partner in identifying, qualifying, and actively managing pipeline opportunities, integrating global data, regulatory analysis, market intelligence, and local execution.

Pipeline Management with the ELSy® platform

ELSy® is the ELS Group’s proprietary and patented platform for pharmaceutical pipeline matchmaking, developed to support strategic decisions based on real, up-to-date, and qualified data.

Differentiators of the ELSy® platform

  • Patented database with over 15,000 active entries for new products.
  • Global coverage with regulatory, pricing, and development status information.
  • Continuous updates with data from the global pharmaceutical R&D pipeline.
  • Integration with strategic client data to create realistic scenarios.
  • A tool geared towards closing deals, not just prospecting.

What Pipeline Management enables our clients to do

With the support of ELS Group’s pharmaceutical consulting services, clients are able to:

  • Optimize business development and sourcing efforts.
  • Gain access to an innovative and qualified pipeline.
  • Reduce time and cost in prospecting and evaluating assets.
  • Making decisions based on regulatory, technical, and commercial feasibility.
  • Track global development trends by therapeutic class.
  • Structuring negotiations with greater predictability and security.

The structure behind the ELS Group's Pipeline Management Service for the Pharmaceutical Industry.

ELS Group’s Pipeline Management is based on an integrated structure that combines:

Pharmaceutical consultants specializing in business development.

Teams with a strong regulatory and quality foundation.

International presence for local support.

Proprietary technology with applied artificial intelligence.

Integration between pipeline, regulatory strategy, and commercial execution.

This approach allows ELS Group to act not only as a data provider, but as a strategic extension of the client’s business development area.

Pipeline Management with Patented Technology and International Validation

ELSy®, the AI-powered pipeline CRM from the ELS Group, has completed the PCT phase of the World Intellectual Property Organization (WIPO).

Bring exclusivity in pipeline management methodology, legal and technological security, real added value to your portfolio and growth strategy, and competitive differentiation in local and international markets to your team.

I want to speak to a Specialist

Frequently asked questions about pipeline management services for the pharmaceutical industry.

ELS Group combines patented technology (ELSy®), regulatory intelligence, technical expertise, and practical execution, offering a complete service focused on real results.

No. ELSy® is a strategic matchmaking platform, integrated with pharmaceutical consulting, that qualifies, prioritizes, and tracks opportunities until the final decision.

Yes. All opportunities go through regulatory and quality pre-qualification, ensuring alignment with target markets.

Pharmaceutical companies, biotechnology companies, distributors, licensors, and organizations seeking to expand or strengthen their portfolio safely.

We operate throughout the entire cycle: identification, qualification, structuring of the negotiation, and follow-up.

ELS Group operates internationally, with a presence in 11 countries, offering regulatory and quality support in Europe and Latin America.

The company has specialized local teams that work in an integrated manner with the main regulatory authorities in each region, allowing it to align global strategies with the specific regulatory requirements of each market.